Michael T. Jaklitsch

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

F. Stephen Hodi, Martín C. Mihm, Robert J. Soiffer et al. · Proceedings of the National Academy of Sciences · 2003 · 997 citations · Full text

Life Sciences, Immunology, Oncology +17

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients

David J. Sugarbaker, Raja M. Flores, Michael T. Jaklitsch et al. · Journal of Thoracic and Cardiovascular Surgery · 1999 · 986 citations · Full text

Medicine, Oncology, Surgery +15

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

F. Stephen Hodi, Marcus O. Butler, Darryl A. Oble et al. · Proceedings of the National Academy of Sciences · 2008 · 648 citations · Full text

Medicine, Immunology, Oncology +17

The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups

Michael T. Jaklitsch, Francine L. Jacobson, John H. M. Austin et al. · Journal of Thoracic and Cardiovascular Surgery · 2012 · 608 citations · Full text

Medicine, Oncology, Cancer Prevention +12

Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.

Shmuel Banai, Michael T. Jaklitsch, Magang Shou et al. · Circulation · 1994 · 602 citations

Medicine, Cardiology, Surgery +11